Motor Neuron Disease: The Contribution of TAR-43 Gene in Amyotrophic Lateral Sclerosis

Motor neuron diseases are a spectrum of neurodegenerative disorders, characterized by their physicochemical propinquity for the voluntary motor systems. The most notorious of these neurodegenerative disorders is amyotrophic lateral sclerosis (ALS), which is a multifocal disorder affecting both lower...

Full description

Saved in:
Bibliographic Details
Main Author: Gorky Guha
Format: Article
Language:English
Published: Jaypee Brothers Medical Publisher 2023-08-01
Series:Bengal Physician Journal
Subjects:
Online Access:https://www.apibpj.com/doi/BPJ/pdf/10.5005/jp-journals-10070-8009
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Motor neuron diseases are a spectrum of neurodegenerative disorders, characterized by their physicochemical propinquity for the voluntary motor systems. The most notorious of these neurodegenerative disorders is amyotrophic lateral sclerosis (ALS), which is a multifocal disorder affecting both lower and upper motor neurons. Amyotrophic lateral sclerosis has been defined as a progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control. Transactive response element (TAR) DNA binding protein 43 (TDP-43) is an ribonucleic acid (RNA)/DNA binding protein contributing to RNA-related metabolism. Hyperphosphorylated and ubiquitinated TDP-43 deposits function as inclusion bodies in the brain and spinal cord which causes ALS. Majority of the ALS cases are sporadic amyotrophic lateral sclerosis’s (SALS’s) and 5–10% of cases are familial amyotrophic lateral sclerosis (FALS), where mutations of the TDP-43 DNA binding protein (TARDBP) gene occur and the rest (90–95%) are due to mutations in other genes like C9ORF72, SOD1, etc. Whether the ALS is familial or sporadic it has been seen that there is a significant contribution of TDP43 protein in the ALS pathology. Thus, the modality of TDP43-based proteinopathies and its involvement in ALS has been the focal point in the study of ALS-mediated neurodegeneration.
ISSN:2582-1202